Delivery Order SPE2DB22D3401-SPE2DB25FT6BA
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on August 15, 2025, for the supply of Synthroid 50 microgram tablets in quantities of 1,000 units, with a ceiling value of $2,012.16. This is a firm fixed price delivery order with an ultimate completion date of August 18, 2025, and represents a non-competitive set-aside award. The contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania, supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,135.68 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Synthroid 50 microgram tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, with performance to take place at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 125 micrograms, with a ceiling value of $1,085.09 and an ultimate completion date of August 28, 2025. This contract is a firm fixed price delivery order with no set-aside designation, awarded through open competition on August 27, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of 1,000 tablets of Synthroid 25 micrograms, with a ceiling value of $1,539.70. This competitively awarded, firm fixed-price delivery order is not subject to any set-aside designation and is scheduled for completion by August 6, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,823.10 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Synthroid 125 micrograms. This competitively awarded, firm fixed-price delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $2,180.65 contract is for the delivery of Synthroid 137 MCG tablets to the Conshohocken, Pennsylvania location. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 and awarded solely to Amerisourcebergen Drug Corp, which serves as the...
- The Defense Logistics Agency awarded a delivery order valued at $37,492.95 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 88 micrograms, a thyroid hormone replacement medication. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,838.73 to AmerisourceBergen Drug Corp for the supply of Synthroid 25 mcg in a quantity of 1,000 units. The contract was competitively awarded without set-aside restrictions under a firm fixed-price delivery order structure, with an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of 1,000 tablets of Synthroid 137 micrograms at a ceiling value of $2,134.25. This is a firm fixed-price delivery order with no set-aside designation, completed by July 31, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a competitive procurement...
- The Defense Logistics Agency (DLA) awarded a $11,495.75 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 125 mcg Synthroid tablets. This contract does not have a set-aside designation and has an ultimate completion date of September 12, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT6BADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,630.09 to AmerisourceBergen Drug Corp for the supply of Synthroid 50 MCG tablets (1,000 units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order under the competitive procurement process. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary distribution operations. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp's extensive portfolio of federal medical procurement contracts demonstrates its critical role as a pharmaceutical distributor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/8/25 |